Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)

Aims: An abundance of epidemiological evidence demonstrates that elevated lipoprotein(a) (Lp(a)) represents a significant contributing risk factor towards the development of cardiovascular disease. In particular, raised Lp(a) may play a mechanistic role in patients with refractory angina. Studies ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Tina Z., Hartley, Adam, Haskard, Dorian, Caga-Anan, Mikhail, Pennell, Dudley J., Collins, Peter, Barbir, Mahmoud, Khamis, Ramzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831935/
https://www.ncbi.nlm.nih.gov/pubmed/33477712
http://dx.doi.org/10.3390/antiox10010132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831935/
https://www.ncbi.nlm.nih.gov/pubmed/33477712
http://dx.doi.org/10.3390/antiox10010132

Ejemplares similares